drugset / Trial / NCT01605942

A Safety and Efficacy Study of a Dexamethasone Drug Delivery System for Postoperative Inflammation and Pain After Cataract Surgery

NCT01605942 ↗

Phase 1 Terminated 8 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a safety and efficacy study of a Dexamethasone Drug Delivery System for anterior segment inflammation and pain following cataract extraction with lens implantation.

Timeline

Start
2012-06
Primary completion
2012-09
Completion
2012-09

Outcome

Outcome not reported

Stopped: “Study terminated due to corporate decision.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule — Other

Indications